ACR appropriateness criteria radiologic management of hepatic malignancy

Brian E. Kouri*, Brian S. Funaki, Charles E. Ray, Ghassan K. Abou-Alfa, Charles T. Burke, Michael D. Darcy, Nicholas Fidelman, Frederick L. Greene, Stephen A. Harrison, Thomas B. Kinney, Jon K. Kostelic, Jonathan M. Lorenz, Ajit V. Nair, Albert A Nemcek Jr, Charles A. Owens, Wael E.A. Saad, George Vatakencherry

*Corresponding author for this work

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Management of hepatic malignancy is a challenging clinical problem involving several different medical and surgical disciplines. Because of the wide variety of potential therapies, treatment protocols for various malignancies continue to evolve. Consequently, development of appropriate therapeutic algorithms necessitates consideration of medical options, such as systemic chemotherapy; surgical options, such as resection or transplantation; and locoregional therapies, such as thermal ablation and transarterial embolization. The authors discuss treatment strategies for the 3 most common subtypes of hepatic malignancy treated with locoregional therapies: hepatocellular carcinoma, neuroendocrine metastases, and colorectal metastases. The ACR Appropriateness Criteria ® are evidence-based guidelines for specific clinical conditions that are reviewed every 2 years by a multidisciplinary expert panel. The guideline development and review include an extensive analysis of current medical literature from peer-reviewed journals and the application of a well-established consensus methodology (modified Delphi) to rate the appropriateness of imaging and treatment procedures by the panel. In those instances in which evidence is lacking or not definitive, expert opinion may be used to recommend imaging or treatment.

Original languageEnglish (US)
Pages (from-to)919-925
Number of pages7
JournalJACR Journal of the American College of Radiology
Volume9
Issue number12
DOIs
StatePublished - Jan 1 2012

Fingerprint

Liver
Neoplasms
Therapeutics
Guidelines
Neoplasm Metastasis
Expert Testimony
Clinical Protocols
Hepatocellular Carcinoma
Hot Temperature
Transplantation
Drug Therapy

Keywords

  • Appropriateness criteria
  • ablation
  • chemoembolization
  • hepatocellular carcinoma
  • liver metastases
  • radioembolization

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Kouri, B. E., Funaki, B. S., Ray, C. E., Abou-Alfa, G. K., Burke, C. T., Darcy, M. D., ... Vatakencherry, G. (2012). ACR appropriateness criteria radiologic management of hepatic malignancy. JACR Journal of the American College of Radiology, 9(12), 919-925. https://doi.org/10.1016/j.jacr.2012.09.002
Kouri, Brian E. ; Funaki, Brian S. ; Ray, Charles E. ; Abou-Alfa, Ghassan K. ; Burke, Charles T. ; Darcy, Michael D. ; Fidelman, Nicholas ; Greene, Frederick L. ; Harrison, Stephen A. ; Kinney, Thomas B. ; Kostelic, Jon K. ; Lorenz, Jonathan M. ; Nair, Ajit V. ; Nemcek Jr, Albert A ; Owens, Charles A. ; Saad, Wael E.A. ; Vatakencherry, George. / ACR appropriateness criteria radiologic management of hepatic malignancy. In: JACR Journal of the American College of Radiology. 2012 ; Vol. 9, No. 12. pp. 919-925.
@article{ffdec7c24f5243288e8cda68fee5e08b,
title = "ACR appropriateness criteria radiologic management of hepatic malignancy",
abstract = "Management of hepatic malignancy is a challenging clinical problem involving several different medical and surgical disciplines. Because of the wide variety of potential therapies, treatment protocols for various malignancies continue to evolve. Consequently, development of appropriate therapeutic algorithms necessitates consideration of medical options, such as systemic chemotherapy; surgical options, such as resection or transplantation; and locoregional therapies, such as thermal ablation and transarterial embolization. The authors discuss treatment strategies for the 3 most common subtypes of hepatic malignancy treated with locoregional therapies: hepatocellular carcinoma, neuroendocrine metastases, and colorectal metastases. The ACR Appropriateness Criteria {\circledR} are evidence-based guidelines for specific clinical conditions that are reviewed every 2 years by a multidisciplinary expert panel. The guideline development and review include an extensive analysis of current medical literature from peer-reviewed journals and the application of a well-established consensus methodology (modified Delphi) to rate the appropriateness of imaging and treatment procedures by the panel. In those instances in which evidence is lacking or not definitive, expert opinion may be used to recommend imaging or treatment.",
keywords = "Appropriateness criteria, ablation, chemoembolization, hepatocellular carcinoma, liver metastases, radioembolization",
author = "Kouri, {Brian E.} and Funaki, {Brian S.} and Ray, {Charles E.} and Abou-Alfa, {Ghassan K.} and Burke, {Charles T.} and Darcy, {Michael D.} and Nicholas Fidelman and Greene, {Frederick L.} and Harrison, {Stephen A.} and Kinney, {Thomas B.} and Kostelic, {Jon K.} and Lorenz, {Jonathan M.} and Nair, {Ajit V.} and {Nemcek Jr}, {Albert A} and Owens, {Charles A.} and Saad, {Wael E.A.} and George Vatakencherry",
year = "2012",
month = "1",
day = "1",
doi = "10.1016/j.jacr.2012.09.002",
language = "English (US)",
volume = "9",
pages = "919--925",
journal = "Journal of the American College of Radiology",
issn = "1558-349X",
publisher = "Elsevier BV",
number = "12",

}

Kouri, BE, Funaki, BS, Ray, CE, Abou-Alfa, GK, Burke, CT, Darcy, MD, Fidelman, N, Greene, FL, Harrison, SA, Kinney, TB, Kostelic, JK, Lorenz, JM, Nair, AV, Nemcek Jr, AA, Owens, CA, Saad, WEA & Vatakencherry, G 2012, 'ACR appropriateness criteria radiologic management of hepatic malignancy', JACR Journal of the American College of Radiology, vol. 9, no. 12, pp. 919-925. https://doi.org/10.1016/j.jacr.2012.09.002

ACR appropriateness criteria radiologic management of hepatic malignancy. / Kouri, Brian E.; Funaki, Brian S.; Ray, Charles E.; Abou-Alfa, Ghassan K.; Burke, Charles T.; Darcy, Michael D.; Fidelman, Nicholas; Greene, Frederick L.; Harrison, Stephen A.; Kinney, Thomas B.; Kostelic, Jon K.; Lorenz, Jonathan M.; Nair, Ajit V.; Nemcek Jr, Albert A; Owens, Charles A.; Saad, Wael E.A.; Vatakencherry, George.

In: JACR Journal of the American College of Radiology, Vol. 9, No. 12, 01.01.2012, p. 919-925.

Research output: Contribution to journalArticle

TY - JOUR

T1 - ACR appropriateness criteria radiologic management of hepatic malignancy

AU - Kouri, Brian E.

AU - Funaki, Brian S.

AU - Ray, Charles E.

AU - Abou-Alfa, Ghassan K.

AU - Burke, Charles T.

AU - Darcy, Michael D.

AU - Fidelman, Nicholas

AU - Greene, Frederick L.

AU - Harrison, Stephen A.

AU - Kinney, Thomas B.

AU - Kostelic, Jon K.

AU - Lorenz, Jonathan M.

AU - Nair, Ajit V.

AU - Nemcek Jr, Albert A

AU - Owens, Charles A.

AU - Saad, Wael E.A.

AU - Vatakencherry, George

PY - 2012/1/1

Y1 - 2012/1/1

N2 - Management of hepatic malignancy is a challenging clinical problem involving several different medical and surgical disciplines. Because of the wide variety of potential therapies, treatment protocols for various malignancies continue to evolve. Consequently, development of appropriate therapeutic algorithms necessitates consideration of medical options, such as systemic chemotherapy; surgical options, such as resection or transplantation; and locoregional therapies, such as thermal ablation and transarterial embolization. The authors discuss treatment strategies for the 3 most common subtypes of hepatic malignancy treated with locoregional therapies: hepatocellular carcinoma, neuroendocrine metastases, and colorectal metastases. The ACR Appropriateness Criteria ® are evidence-based guidelines for specific clinical conditions that are reviewed every 2 years by a multidisciplinary expert panel. The guideline development and review include an extensive analysis of current medical literature from peer-reviewed journals and the application of a well-established consensus methodology (modified Delphi) to rate the appropriateness of imaging and treatment procedures by the panel. In those instances in which evidence is lacking or not definitive, expert opinion may be used to recommend imaging or treatment.

AB - Management of hepatic malignancy is a challenging clinical problem involving several different medical and surgical disciplines. Because of the wide variety of potential therapies, treatment protocols for various malignancies continue to evolve. Consequently, development of appropriate therapeutic algorithms necessitates consideration of medical options, such as systemic chemotherapy; surgical options, such as resection or transplantation; and locoregional therapies, such as thermal ablation and transarterial embolization. The authors discuss treatment strategies for the 3 most common subtypes of hepatic malignancy treated with locoregional therapies: hepatocellular carcinoma, neuroendocrine metastases, and colorectal metastases. The ACR Appropriateness Criteria ® are evidence-based guidelines for specific clinical conditions that are reviewed every 2 years by a multidisciplinary expert panel. The guideline development and review include an extensive analysis of current medical literature from peer-reviewed journals and the application of a well-established consensus methodology (modified Delphi) to rate the appropriateness of imaging and treatment procedures by the panel. In those instances in which evidence is lacking or not definitive, expert opinion may be used to recommend imaging or treatment.

KW - Appropriateness criteria

KW - ablation

KW - chemoembolization

KW - hepatocellular carcinoma

KW - liver metastases

KW - radioembolization

UR - http://www.scopus.com/inward/record.url?scp=84926231774&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84926231774&partnerID=8YFLogxK

U2 - 10.1016/j.jacr.2012.09.002

DO - 10.1016/j.jacr.2012.09.002

M3 - Article

C2 - 23206650

AN - SCOPUS:84926231774

VL - 9

SP - 919

EP - 925

JO - Journal of the American College of Radiology

JF - Journal of the American College of Radiology

SN - 1558-349X

IS - 12

ER -